Study Completed

Primary PAH (Pulmonary Arterial Hypertension)

Bayer Identifier:

91613

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

2006-005798-23

EU CT Number:

Not Available

Crossover St.: Iloprost Nebulizer vs. Prodose Neb.

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

18 - 45 Years

Inclusion Criteria
-
Exclusion Criteria
-

Trial summary

Enrollment Goal

Trial Dates

April 2007 - May 2007

Phase

Phase 1

Could I Receive a placebo

N/A

Products

Ventavis (Iloprost, BAYQ6256)

Accepts Healthy Volunteer

N/A

Where to participate

Status	Institution	Location
Completed	Bayer Pharma AG	Berlin, 13353, Germany

Trial design

A randomized, open-label, single center, crossover study to compare pharmacokinetics in healthy male volunteers following inhalation of 5 mcg iloprost as aerosol generated from Ventavis by two distinct nebulizing devices

Trial Type

Interventional

Intervention Type

N/A

Trial Purpose

N/A

Allocation

N/A

Blinding

N/A

Assignment

N/A

Trial Arms

N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.